Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 349

Pandemics in perspective

Epidemics and pandemics are an integral part of human history, with each outbreak bearing both social and economic costs. The world has endured a few outbreaks over the past century, and if the early decades of this new century are a reliable indicator, we can expect to see more in the 2020s and beyond.

The first table below outlines the main epidemics and pandemics in recent history, when and where they struck, and the resulting death toll.

Impact on coronavirus will prove severe

Of the above list, the two standouts were the Spanish Flu and HIV/AIDS. The first, which occurred in 1918–20, resulted in over 50 million deaths (over 2.5% of the population). The second, which was first observed in 1960s and is still present today, has resulted in 30 million deaths to date (0.6% of the average population until now).

Coronavirus, or COVID-19, originated in China in December 2019 and has since spread rapidly worldwide. The economic impact to global GDPs and stock markets is proving more severe than was anticipated in mid-February, and we are yet to see the full extent of the damage.

The epicenter of the COVID-19 pandemic, China, has expanded at a record-breaking rate since adopting a state-controlled market economy. Averaging 8.7% GDP growth since 1970, the nation has not seen a recession since Mao Zedong’s death in 1976. However, China’s economy has trended downwards in recent years, as observed in the below chart.

At present, China is also taking an economic hit from swine fever, which is affecting pig production. Now coronavirus is affecting China’s population, trade and general economy to an unknown extent. This setback has in turn affected other economies around the world, including Australia’s export trade of tourism, higher education and minerals.

If the 2002–04 SARS epidemic is any guide, these conditions may only affect economic performance in 2020. However, a looming debt bubble in China may see other problems emerge further into this decade.

Why is the latest pandemic such a worry?

In short, it’s a worry because the world economy now relies upon a lot more international interdependence between economies and businesses. Exports have trebled their percentage share of the world’s GDP from 10% to 30% over the past 70 years, as we see in the next exhibit.

So, the world’s GDP is more vulnerable than ever to any economic downturns resulting from pandemic activity, even if the disease itself is not as virulent on a social scale as, say, the Spanish Flu or AIDS.

A world recession? Doubtful. But a recession in some countries? Quite likely.

Any nation with a growth in 2020 of under 1.5% could be exposed to a recession. If those economies also have high shares of mining, manufacturing, wholesaling, retail and tourism in their industry mix, then they have increased vulnerability due to the high interconnectivity of trade these days.

Australia is vulnerable as a result

The first chart below shows our export mix (being almost 25% our GDP) with the vulnerable minerals and tourism industries accounting for nearly two-thirds of those exports. These are two of the main industries at risk due to slowing global trade and problems in China.

The second chart shows our mix of industries in our $2 trillion economy.

Our small dependence on manufacturing is a big help, but mining is a bigger industry these days.

We may escape a recession but only with a sooner-rather-than-later stabilisation of the viral pandemic and abatement of the fear contagion.

The human impact and equity markets

Of course, the human impact of the coronavirus, separate from the economic impact, cannot be ignored. Shorter quarantine periods, coupled with apparently longer gestation periods than originally thought, have contributed to a faster and greater spread than was anticipated. On the plus side, advances in modern medicine mean vaccines may now become available in record time. But despite a relatively small number of deaths so far, there is no certainty as to how long the pandemic will last.

In times like these, we must consult the experts. It is worth dusting off Peter Curson’s and Brendan McRandle’s 2005 paper, Plague Anatomy: Health Security from Pandemics to Bioterrorism, which addresses the challenge of disease control within the context of national security.

All that said, while stock markets are in meltdown in the early days of March, they have a habit of exaggerating threats as well as perceived opportunities, as seen below. Bond rates can be expected to now stay low for a longer time, but the stock markets could make up a lot of losses as we enter 2021.

Perhaps the best news, for those prepared to take the long-term view, is that complacency in both health and interconnective trade dependencies has been replaced by better planning, safer strategies and contingency plans.

 

Phil Ruthven is Founder of the Ruthven Institute, Founder of IBISWorld and widely-recognised as Australia’s leading futurist.

 

RELATED ARTICLES

Uncharted waters, 2020 and beyond

Internet of things and the power of 5G technology

banner

Most viewed in recent weeks

Why we’re not buying the market yet

The Australian market bounced back last Friday (13th) and Monday (16th) tempting analysts to call the bottom of the coronavirus scare. This is too early as the impact on companies is not yet evident.

Drawdown reductions needed for retirees - UPDATED POLICY

During the GFC, in the face of rapid falls in super balances, the minimum drawdowns required for pensions were reduced by 50% to help preserve overall retirement savings. It's time for a repeat.

What are the possible economic effects of COVID-19 on the world economy?

In a widely-quoted scenario using estimated attack and fatality rates of coronavirus, about 0.07% of the population of the US dies. That's about 230,000 people, which the market is not ready for.

Note to Australia: be more French in the COVID-19 war

Andrew Baker is well-known as a superannuation consultant. Now working in the UK, he was caught in France with his family and is in lockdown. He worries Australian policy was too slow.

Optimism among forecasts of the COVID-19 peak

This detailed analysis of infections, deaths, drugs and vaccines includes an optimistic scenario: perhaps US and Australian infection numbers will peak in early to mid-April with a decline after.

How stock markets recover and the perils of timing markets

Investors who try to time buying and selling shares risk missing the strongly positive days which drive good performance, while over the long term, stock markets will recover from price falls.

Latest Updates

Economy

How $200 billion is magically created

Australia is in a relatively good position to borrow $200 billion, with the RBA using printed money to buy bonds in the market. The long-term consequences are better than the alternative.

Investment strategies

Howard Marks' latest on 'Which way now?'

Howard Marks is the largest investor in the world in distressed securities. What does he think after checking the virus positives and negatives, and how much has he changed his mind in only a few days?

Latest from Morningstar

Four stages of a typical bear market - but is this typical?

Bear markets caused by recession fears follow a pattern, but we have never seen anything like coronavirus. If financial stimulus and medicine prove ineffective, all bets are off. 

Economy

Small business in path of COVID-19 tsunami

The turning point in this crisis will be when the number of new COVID-19 cases starts to decrease. Until then, can we mitigate the damage to businesses and the economy so that we can snap back?

Investment strategies

Why technology stocks are good for the future

Over the long term, the technology sector has a vital role to make the essential transition to a more sustainable global economy and a cleaner planet. We highlight a few names with strong prospects.

Sponsors

Alliances

© 2020 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use.
Any general advice or class service prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, has been prepared by without reference to your objectives, financial situation or needs. Refer to our Financial Services Guide (FSG) for more information. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.